Medicine guide
Rybrevant Faspro
2240 mg/14mL + 28000 mg/14mL · Injection
- Prescription only
- Endoglycosidase
- Active substance
- Amivantamab and Hyaluronidase-Lpuj (human Recombinant)
- Made by
- Janssen Biotech, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Janssen Biotech, Inc. |
|---|---|
| Active substance | Amivantamab and Hyaluronidase-Lpuj (human Recombinant) |
| Strength | 2240 mg/14mL + 28000 mg/14mL |
| Form | Injection |
| Route | Subcutaneous |
| Packs | 1 VIAL, SINGLE-DOSE in 1 CARTON / 14 mL in 1 VIAL, SINGLE-DOSE |
| NDC | 57894-514 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Injection4 products
- 1600 mg/10mL + 20000 mg/10mL
- 2240 mg/14mL + 28000 mg/14mL
- 2400 mg/15mL + 30000 mg/15mL
- 3520 mg/22mL + 44000 mg/22mL
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
Rybrevant Faspro1600 mg/10mL + 20000 mg/10mLPrescription only Janssen Biotech, Inc. · Amivantamab and Hyaluronidase-Lpuj (human Recombinant)Rybrevant Faspro2400 mg/15mL + 30000 mg/15mLPrescription only Janssen Biotech, Inc. · Amivantamab and Hyaluronidase-Lpuj (human Recombinant)Rybrevant Faspro3520 mg/22mL + 44000 mg/22mLPrescription only Janssen Biotech, Inc. · Amivantamab and Hyaluronidase-Lpuj (human Recombinant)
See every product with Amivantamab and Hyaluronidase-Lpuj (human Recombinant)